Vesprini, D., Narod, S.A., Trachtenberg, J., Crook, J., Jalali, F., Preiner, J., Sridhar, S. and Bristow, R.G. 2013. The therapeutic ratio is preserved for radiotherapy or cisplatin treatment in BRCA2-mutated prostate cancers. Canadian Urological Association Journal. 5, 2 (Apr. 2013), E31-E35. DOI:https://doi.org/10.5489/cuaj.619.